Neuroleptic Drugs in the Management of Behavioral Symptoms of Alzheimer’s Disease (Q53181157)

12 May 2018

reason for preferred rank

title

Neuroleptic Drugs in the Management of Behavioral Symptoms of Alzheimer’s Disease (English)

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

26 October 2022

Neuroleptic drugs in the management of behavioral symptoms of Alzheimer's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1676507

26 October 2022

author name string

L. E. Tune

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1676507

26 October 2022

C. Steele

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1676507

26 October 2022

T. Cooper

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1676507

26 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1676507

26 October 2022

publication date

1 June 1991

1 reference

12 May 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S0193953X18303125?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

https://api.elsevier.com/content/article/PII:S0193953X18303125?httpAccept=text/plain

26 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Psychiatric Clinics of North America

26 October 2022

published in

1 reference

12 May 2018

volume

14

1 reference

12 May 2018

issue

2

1 reference

12 May 2018

page(s)

353-373

1 reference

12 May 2018

The value of chemotherapy in senile mental distrubances. Controlled comparison of chlorpromazine, reserpine-pipradrol, and opium.

cites work

1

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Efficacy of antipsychotic medications in behaviorally disturbed dementia patients

26 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Unnecessary Use of Tranquillizers in Elderly Patients

26 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Thiothixene in the treatment of diseases of the senium

26 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Loxapine succinate as a neuroleptic agent: evaluation in two populations of elderly psychiatric patients

26 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Behavior problems in an urban nursing home

26 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Evaluation of thioridazine in the aged

26 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Alleviating agitation, apprehension, and related symptoms in geriatric patients: A double-blind comparison of a phenothiazine and a benzodiazepien

26 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

A Controlled Trial of Amantadine in Drug-Induced Extrapyramidal Disorders

26 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Altercations among institutionalized psychogeriatric patients

26 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

26 October 2022

“Mini-mental state”

15

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

The use of mesoridazine in geriatrics

26 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Depot neuroleptics in the treatment of behavioral disorders in patients with Alzheimer's disease

26 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

The effects that patients have on their families in a community care and a control psychiatric service--a two year follow-up.

26 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Acetophenazine for hyperactive geriatric patients

26 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

The use of trifluoperazine in geriatric patients with chronic brain syndrome.

26 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Mellaril in the treatment of the geriatric patient

26 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

The use of thioridazine (Mellaril) in aged people

26 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Pimozide in the management of psychotically agitated demented patients

26 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

26 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Thiothixene in the treatment of geriatric patients with chronic organic brain syndrome

26 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Pharmacologic treatment of agitation associated with dementia

26 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Prevalence of mental illness in a community nursing home.

26 October 2022

34

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

A new scale for clinical assessment in geriatric populations: Sandoz Clinical Assessment--Geriatric (SCAG).

26 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

HALOPERIDOL IN THE PSYCHIATRIC DISORDERS OF OLD AGE

26 October 2022

39

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Troublesome and disruptive behaviors in dementia. Relationships to diagnosis and disease severity

26 October 2022

40

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Behavioral disturbance in dementia of the Alzheimer's type.

26 October 2022

41

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Clinical evaluation of haloperidol in geriatric patients

26 October 2022

43

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Haloperidol versus thioridazine for hospitalized psychogeriatric patients: double-blind study

26 October 2022

44

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Psychogeriatric dependency rating scales (PGDRS): a method of assessment for use by nurses

26 October 2022

45

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Behavioral problems among patients in skilled nursing facilities.

26 October 2022

46

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

26 October 2022

Identifiers

1 reference

12 May 2018